Russell Investments Group
MEDP icon

Russell Investments Group’s Medpace MEDP Stock Holding History

Russell Investments Group’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.5M Sell
46,249
-16,501
-26% -$7.62M 0.02% 656
2026
Q1 		$30.1M Buy
62,750
+3,129
+5% +$1.6M 0.03% 505
2025
Q4 		$33.5M Sell
59,621
-4,958
-8% -$2.81M 0.04% 464
2025
Q3 		$33.2M Sell
64,579
-13,930
-18% -$6.08M 0.04% 452
2025
Q2 		$24.6M Buy
78,509
+9,536
+14% +$2.86M 0.03% 510
2025
Q1 		$21M Buy
68,973
+37,442
+119% +$12.6M 0.03% 559
2024
Q4 		$10.5M Buy
31,531
+10,588
+51% +$3.59M 0.01% 795
2024
Q3 		$6.99M Sell
20,943
-12,107
-37% -$4.6M 0.01% 1022
2024
Q2 		$13.6M Sell
33,050
-4,427
-12% -$1.75M 0.02% 677
2024
Q1 		$15.1M Sell
37,477
-2,418
-6% -$850K 0.02% 654
2023
Q4 		$12.2M Buy
39,895
+2,038
+5% +$550K 0.02% 696
2023
Q3 		$9.17M Sell
37,857
-6,509
-15% -$1.66M 0.02% 786
2023
Q2 		$10.6M Sell
44,366
-8,290
-16% -$1.72M 0.02% 750
2023
Q1 		$9.82M Sell
52,656
-1,832
-3% -$379K 0.02% 777
2022
Q4 		$11.6M Sell
54,488
-43,996
-45% -$8.79M 0.02% 710
2022
Q3 		$15.5M Buy
98,484
+28,856
+41% +$4.6M 0.03% 580
2022
Q2 		$10.4M Sell
69,628
-29,747
-30% -$4.31M 0.02% 762
2022
Q1 		$16.3M Sell
99,375
-37,273
-27% -$6.15M 0.03% 632
2021
Q4 		$29.7M Buy
136,648
+4,502
+3% +$943K 0.05% 466
2021
Q3 		$25M Buy
132,146
+26,884
+26% +$4.9M 0.04% 509
2021
Q2 		$18.6M Sell
105,262
-2,672
-2% -$461K 0.03% 636
2021
Q1 		$17.7M Buy
107,934
+23,834
+28% +$3.65M 0.03% 646
2020
Q4 		$11.7M Sell
84,100
-17,386
-17% -$2.19M 0.02% 769
2020
Q3 		$11.3M Sell
101,486
-2,831
-3% -$327K 0.02% 701
2020
Q2 		$9.6M Sell
104,317
-28,175
-21% -$2.4M 0.02% 752
2020
Q1 		$9.78M Buy
132,492
+22,978
+21% +$1.99M 0.03% 661
2019
Q4 		$9.17M Sell
109,514
-115,558
-51% -$8.94M 0.02% 892
2019
Q3 		$18.8M Buy
225,072
+3,792
+2% +$287K 0.04% 561
2019
Q2 		$14.3M Buy
221,280
+358
+0.2% +$20.6K 0.03% 704
2019
Q1 		$12.9M Buy
220,922
+19,605
+10% +$1.17M 0.02% 763
2018
Q4 		$10.5M Buy
201,317
+4,352
+2% +$239K 0.02% 781
2018
Q3 		$11.7M Buy
196,965
+25,642
+15% +$1.4M 0.02% 847
2018
Q2 		$7.38M Buy
171,323
+34,121
+25% +$1.38M 0.02% 1074
2018
Q1 		$4.82M Buy
137,202
+66,002
+93% +$2.41M 0.01% 1383
2017
Q4 		$2.6M Buy
71,200
+32,345
+83% +$1.13M ﹤0.01% 1687
2017
Q3 		$1.24M Buy
38,855
+17,983
+86% +$549K ﹤0.01% 2034
2017
Q2 		$605K Sell
20,872
-10,700
-34% -$300K ﹤0.01% 2340
2017
Q1 		$942K Buy
31,572
+11,092
+54% +$358K ﹤0.01% 2129
2016
Q4 		$732K Buy
+20,480
New +$682K ﹤0.01% 2328

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Russell Investments Group's MEDP Position: Q2 2026 in Review

Russell Investments Group reduced its Medpace (MEDP) stake by 26% in Q2 2026, selling an estimated $7.62M and leaving 46,249 shares worth $24.5M. The position accounts for 0.02% of the portfolio, ranked #656.

Russell Investments Group first reported a position in MEDP in Q4 2016 and has held it in 39 quarters since. The position peaked at $33.5M in Q4 2025. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Russell Investments Group held 46,249 shares of Medpace worth $24.5M as of Q2 2026.
  • Russell Investments Group sold 16,501 Medpace shares in Q2 2026, an estimated $7.62M.
  • Medpace made up 0.02% of Russell Investments Group's portfolio in Q2 2026, its #656 holding.
  • Russell Investments Group first reported a position in Medpace in Q4 2016 and has held it in 39 quarters since.
  • Russell Investments Group's Medpace position peaked at $33.5M in Q4 2025.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.